$CLRB can rise in the next days

Contextual immersion trading strategy idea.

Cellectar Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer.

The demand for shares of the company looks higher than the supply.

This and other conditions can cause a rise in the share price in the next days.

So I opened a long position from $1,95;
stop-loss — $1,65.

Information about take-profits will be later.

Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.

If you like my content, you can subscribe to the news and receive my fresh ideas.

Thanks for being with me!

Handel aktiv:

1/4 closed at $2,25
3/4 closed at $1,95